Chapel Hill drug developer Achelios Therapeutics raised $350,000 toward a goal of $2 million.
This is the second round of funding for the company, after it raised more than $3 million in 2014.
The company is developing topical drugs to treat migraines and related pain. The company's name is derived from the mythological Greek moon goddess "Achelois," which loosely translates as "she who washes away pain."
Achelios presented positive data on its lead product candidate, Topofen, in late December.…
Chapel Hill drug developer Achelios Therapeutics raised $350,000 toward a goal of $2 million.
This is the second round of funding for the company, after it raised more than $3 million in 2014.
The company is developing topical drugs to treat migraines and related pain. The company's name is derived from the mythological Greek moon goddess "Achelois," which loosely translates as "she who washes away pain."
Achelios presented positive data on its lead product candidate, Topofen, in late December.…